The global oral vaccine market is expected to be around US$ 61 Billion by 2027 at a CAGR of 7% in the given forecast period.
Oral vaccines are safe and simple to administer and convenient for all ages. They have been successfully developed to safeguard from several infectious diseases uninheritable through oral transmission. Oral delivery of vaccines represents the foremost enticing mode of administration over other routes of delivery because of the actual fact that the oral vaccination is noninvasive, safe and easy to execute, showing good patient compliance and clinical usefulness.
The growth of the market is attributed to the rising prevalence of diseases, increasing government and nongovernment funding for vaccine development, and increasing companies’ initiatives to enhance R&D, Newer and more expensive vaccines are coming into the market faster than ever before.
Market Insights
The global oral vaccine market is segregated on the basis of Type as Rotavirus Vaccine, Cholera Vaccine, Oral Polio Vaccine, and Others. Based on Application the global oral vaccine market is segmented in Public health care units and Private health care units.
The global oral vaccine market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The oral vaccine market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, and others are among the major players in the global oral vaccine market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Oral vaccine Market has been segmented as below:
Oral vaccine Market, By Type
Oral vaccine Market, By Application
Oral vaccine Market, By Region
Oral vaccine Market, By Company
The report covers:
Report Scope:
The global oral vaccine market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global oral vaccine market share. Major industry players with significant revenue share include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Global Water Testing & Analysis Market
Remote Sensing Technology Market
Global Flexible Heaters Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Oral vaccine Market, By Type
5.1 Introduction
5.2 Rotavirus Vaccine
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Cholera Vaccine
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Oral Polio Vaccine
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Others
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Oral vaccine Market, By Application
6.1 Introduction
6.2 Public health care units
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Private health care units
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Oral vaccine Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America oral vaccine, By Type
7.2.2 North America oral vaccine, By Application
7.3 Europe
7.3.1 Europe oral vaccine, By Type
7.3.2 Europe oral vaccine, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific oral vaccine, By Type
7.4.2 Asia-Pacific oral vaccine, By Application
7.5 Rest of the World
7.5.1 Rest of the World oral vaccine, By Type
7.5.2 Rest of the World oral vaccine, By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Merck
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 GSK
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Sanofi
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Lanzhou Institute
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Serum Institute
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Valneva
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Shanghai United Cell
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Bibcol
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 PaxVax
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Vabiotech
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Oral vaccine Market has been segmented as below:
Oral vaccine Market, By Type
Oral vaccine Market, By Application
Oral vaccine Market, By Region
Oral vaccine Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
